Quarterly report pursuant to Section 13 or 15(d)

Warrants (Details Narrative)

v3.8.0.1
Warrants (Details Narrative) - USD ($)
3 Months Ended
Jan. 26, 2018
Mar. 31, 2018
Mar. 31, 2017
Class of Warrant or Right [Line Items]      
Warrants exercised  
Warrant to purchase of common stock   2,288,500  
Weighted average exercise price of warrants   $ 6.33  
Weighted average remaining life of warrants   3 years 7 months 21 days  
Additional paid in capital, fair value of warrant issued   $ 6,215,225  
Cystic Fibrosis Foundation warrants [Member]      
Class of Warrant or Right [Line Items]      
Warrant to purchase of common stock 1,000,000 1,000,000  
Weighted average exercise price of warrants $ 13.20 $ 13.20  
Warrant exercisable shares of common stock 500,000 500,000  
Warrant expires date Jan. 26, 2025    
Additional paid in capital, fair value of warrant issued   $ 6,215,225  
Cystic Fibrosis Foundation warrants [Member] | Investment Agreement [Member]      
Class of Warrant or Right [Line Items]      
Warrant exercisable shares of common stock 500,000 500,000  
Warrant expires date   Jan. 26, 2025